Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)

NCT01116804 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01116804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01116804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
Lead sponsor
University Hospital, Ghent
Phase
Phase 1
Overall status
Completed
Start date
June 16, 2010
Completion date
January 20, 2020
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary liver cancer